Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$921,602
+$62,130 QoQ
Shares Held
7,172
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,188
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AFFINITY INVESTMENT ADVISORS, LLC holds $11,731,822 across 9 Drug Manufacturers - General names. MRK ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,898 | $2,239,092 | |
| 2 | JNJ |
Johnson & Johnson
|
8,462 | $2,149,094 | |
| 3 | PFE |
Pfizer Inc
|
79,689 | $1,918,911 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
30,557 | $1,760,694 | |
| 5 | AMGN |
Amgen Inc
|
4,328 | $1,567,255 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
7,172 | $921,602 | |
| 7 | LLY |
ELI LILLY & Co
|
360 | $431,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,040 | $384,073 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $921,602 | 7,172 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $859,472 | 7,145 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,322,065 | 12,560 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,068,009 | 12,725 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,287,774 | 16,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,483,553 | 16,528 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,661,813 | 16,705 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,658,893 | 23,414 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,926,136 | 23,636 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,645,597 | 20,050 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,997,137 | 18,319 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,338,612 | 22,716 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,825,670 | 24,488 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,251,384 | 30,561 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,645,698 | 41,872 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,904,077 | 45,333 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,248,248 | 46,597 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,017,963 | 36,782 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,880,974 | 37,591 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,847,194 | 37,907 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,564,310 | 32,973 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,449,085 | 44,741 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,647,051 | 44,585 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,678,668 | 44,348 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,292,326 | 42,575 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,152,834 | 53,975 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||